Moscow
AstraZeneca is planning to build a $150 million pharmaceutical manufacturing facility near Moscow in Russia. Construction will begin in April of 2011 with production beginning in spring of 2013. The facility will manufacture treatments for cancer, cardiovascular health, and other conditions.
